Join our sponsored symposium Optimizing Treatment of Poor Prognosis Patients as part of the ESHRE 2019 Scientific Program, on Tuesday 25 June in the Mozart Room, at the Congress Center.

Opening with an exploration of the definition of a ‘poor prognosis patient’, expert talks will introduce some of the treatments that have been shown to help improve outcomes for this patient subgroup.

Each clinic manages these patients and their journeys differently and the discussion will consider how an integrated, more personalized approach to their treatment and care may improve their chances of achieving a successful pregnancy.

Following the symposium, we welcome you to join us at our stand in the exhibition hall to continue the conversation and ask the speakers and our staff further questions.

Session Chair 

Ippokratis Sarris MD

Consultant Gynecologist and Director, King’s Fertility Clinic, UK

Optimizing Sperm Selection for ART
using HBA and PICSI

Lucy Richardson PhD

Laboratory Director, Hertfordshire and Essex Fertility Centre, UK

Reflections and Results Following the use of
GM-CSF Enriched Culture Media at CARE Fertility

Sue Montgomery PhD

Laboratory Manager, CARE Fertility Clinic Manchester, UK

Improving ART Prognosis with Genomic Testing: Endometrial Receptivity Testing and PGT

Tony Gordon PhD

Vice President of Global Genomics Business Development, CooperSurgical Fertility and Genomic Solutions

Want to know more about optimizing treatments
for poor prognosis patients?

Meet our experts at the CooperSurgical stand | Tuesday 25 June at 15:30

Carry on the conversation by joining our symposium speakers and product experts.
They will be on hand to answer your questions and expand upon the topics raised in the session.
2019-06-14T11:10:35+01:00June 14th, 2019|
X